全球病毒過濾市場規模：地區、範圍和預測

病毒過濾市場規模及預測

2024 年病毒過濾市場規模為 45.2612 億美元，預計到 2031 年將達到 107.1203 億美元，2024 年至 2031 年複合年增長率為 11.37%。

病毒過濾的全球市場推動因素。

病毒過濾市場的市場推動因素可能受到多種因素的影響。

促進生物製藥生產：

高效的病毒過濾技術對於維持生物製品（包括單株抗體、疫苗和治療性蛋白質）的安全性和純度是必要的。

慢性病增加：

由於癌症、糖尿病和自體免疫疾病等慢性疾病的增加，對生物製藥的需求不斷增加。因此，對病毒過濾器以保持這些藥物的完整性的需求不斷增加。

嚴格的監理準則：

FDA 和 EMA 等監管機構對生物製藥生產中病毒的安全性制定了嚴格的規定。遵守這些標準需要先進的病毒過濾技術。

技術進步

高容量過濾器和先進的過濾系統是病毒過濾創新的例子，它們提高了效率和可靠性，對生物製藥企業更具吸引力。

擴大研發投入：

推動市場的關鍵因素之一是生物製藥公司增加研發支出，以開發新的和增強的病毒過濾技術。

生技產業的成長：

生物技術領域正在迅速擴大，特別是在發展中國家，對與病毒過濾相關的服務和產品的需求正在增加。

關注仿製藥和生物相似藥：

對病毒過濾技術的需求是由生物相似藥和仿製藥市場不斷擴大所推動的。這些需要與原始生物製劑的品質相稱的嚴格的病毒過濾程序。

病毒污染髮生率增加：

對生物藥物病毒污染的認識和擔憂促使越來越多地使用病毒過濾作為基本的安全預防措施。

一次性使用科技的接受度：

病毒過濾市場正在擴大，因為生物製藥製造傾向於一次性系統，因為一次性系統成本低且交叉污染風險低。

零件製造組織 (CMO) 的發展：

CMO 在生物製藥製造過程中的重要性日益增加，增加了對滿足客戶各種需求的卓越病毒過濾解決方案的需求。

全球病毒過濾市場的阻礙因素

有幾個因素可能會成為病毒過濾市場的限制和挑戰。其中包括：

過濾系統成本高：

病毒過濾系統及相關耗材成本高昂，導致中小型企業難以購買。這種高昂的初始費用可能是實施和廣泛使用的主要障礙。

先進且嚴格的監理需求：

生物製藥產業受到嚴格監管，在病毒過濾方面有嚴格的規定，以確保產品安全。遵守這些法規既耗時又昂貴，並且可能會延遲產品開發和市場開發。

技術難度：

理論上很難創建一個高效的病毒過濾系統，能夠處理各種類型的病毒而不降低產品品質或生產率。這種複雜性可能會延遲新過濾方法的開發和應用。

熟練勞動力限制：

病毒過濾系統的操作需要特定的知識和能力。缺乏監督此類複雜系統的熟練人員可能會阻礙該領域的擴展。

供應鏈問題：

用於病毒過濾的設備和耗材容易受到供應鏈的影響。流行病、自然災害和不穩定的地緣政治局勢等事件可能導致關鍵零件和資源的短缺。

競爭環境：

病毒過濾器市場競爭極為激烈，老牌公司佔據主導地位。憑藉強大的市場影響力和眾多忠實客戶，這些歷史悠久的公司可能很難讓新進入者與之競爭。

經濟衰退：

生物製藥產業的研發資金可能會受到經濟波動和衰退的影響。資金減少可能會導致對新病毒過濾技術和技術的投資減少。

目錄

第1章全球病毒過濾市場簡介

• 市場概覽
• 調查範圍
• 先決條件

第 2 章執行摘要

第3章研究方法

• 資料探勘
• 驗證
• 主要來源
• 資料來源列表

第4章全球病毒過濾市場展望

• 摘要
• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 波特的五力模型
• 價值鏈分析
• 監理框架

第5章全球病毒過濾市場（按應用）

• 醫療設備
• 純水
• 空氣淨化
• 生物製品
  • 疫苗和治療藥物
  • 血液和血液製品
  • 細胞/基因治療產品
  • 其他

第 6 章全球病毒過濾市場：依產品

• 試劑盒和試劑
• 過濾系統
• 服務
• 其他產品

第 7 章全球病毒過濾市場：依最終使用者劃分

• 製藥和生技公司
• 合約研究組織
• 學術研究所
• 醫療器材公司

第 8 章全球病毒過濾市場：依地區劃分

• 摘要
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
• 世界其他地區

第9章全球病毒過濾市場競爭格局

• 摘要
• 各公司的市佔率
• 供應商情況
• 主要發展策略

第10章公司簡介

• Merck & Co.
• GE Healthcare
• Thermo Fisher Scientific, Inc.
• Lonza Group Ltd.
• Sartorius AG
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Pall Corporation
• Charles River Laboratories

第11章 附錄

• 關聯調查

Virus Filtration Market Size And Forecast

Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031 , growing at a CAGR of 11.37% from 2024 to 2031. Global Virus Filtration Market Drivers The market drivers for the Virus Filtration Market can be influenced by various factors. These may include: Boosting the Production of Biopharmaceuticals: Efficient viral filtration techniques are necessary to preserve the safety and purity of biologics, which include monoclonal antibodies, vaccines, and therapeutic proteins, due to the growing demand for these products.

Increasing Rate of Chronic Illnesses:

The demand for biopharmaceutical goods has increased because to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has resulted in a greater requirement for viral filtering to preserve the integrity of these medicines.

Tight Regulating Guidelines:

Strict regulations are in place for viral safety in the manufacturing of biopharmaceuticals from regulatory organisations including the FDA and EMA. Advanced viral filtration technologies are required in order to comply with these criteria.

Technological Progress:

High-capacity filters and sophisticated filtration systems are examples of virus filtration innovations that have improved efficiency and dependability, making them more appealing to biopharmaceutical businesses.

Growing R&D Investment:

One important factor driving the market is biopharmaceutical firms' increased expenditure in R&D to create novel and enhanced viral filtration techniques.

Growth of the Biotechnology Industry:

The biotechnology sector is expanding quickly, especially in developing nations, which increases the need for services and goods related to viral filtering.

Pay Attention to Generics and Biosimilars:

The demand for virus filtration technologies is driven by the expanding market for biosimilars and generic biologics, which need strict virus filtration procedures to match the quality of original biologics.

Growing Viral Contamination Incidence:

The use of virus filtration as an essential safety precaution has expanded due to awareness of and worry over viral contamination in biopharmaceutical products.

Acceptance of One-Time Use Technologies:

The market for viral filtration is expanding due to the tendency in biopharmaceutical manufacturing towards single-use systems because of their low cost and lower danger of cross-contamination.

Component Manufacturing Organisations (CMOs) are Growing:

The need for superior virus filtering solutions to satisfy a range of customer demands is fueled by the growing significance of CMOs in the biopharmaceutical production process.

Global Virus Filtration Market Restraints

Several factors can act as restraints or challenges for the Virus Filtration Market. These may include:

High Filtration System Cost:

The cost of virus filtration systems and related consumables makes it difficult for small and medium-sized businesses to afford them. This expensive initial outlay may act as a major deterrent to adoption and admission.

Sophisticated and Tight Regulatory Needs:

The biopharmaceutical sector is heavily regulated, and strict rules for viral filtering are in place to guarantee the safety of the products. It may take a while and be expensive to comply with these rules, which could postpone product development and market launch.

Technology Difficulties:

It is theoretically difficult to create efficient viral filtering systems that can handle different kinds of viruses without lowering the product's quality or production. The development and application of new filtration methods may be slowed down by these complications.

Restricted Skilled Labour:

Systems for filtering viruses require specific knowledge and abilities to operate. The insufficiency of skilled personnel to oversee these intricate systems can impede the expansion of the sector.

Problems with the supply chain:

Equipment and consumables used in viral filtration have a susceptible supply chain. Critical parts and resources may become scarce due to events like pandemics, natural disasters, or unstable geopolitical conditions.

Competitive Environment:

The market for viral filtering is extremely competitive, with well-established companies holding a dominant position. Due to their strong market presence and devoted clientele, these well-established businesses may be tough for newcomers to compete with.

Economic Recessions:

Funding for research and development in the biopharmaceutical industry may be impacted by economic volatility or recession. Decreased funding may result in less money being invested on novel viral filtration techniques and technologies.

Global Virus Filtration Market Segmentation Analysis

The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User, And Geography.

Virus Filtration Market, By Type

• Kits and Reagents
• Services
• Filtration Systems
• Others

Based on Type, the market is segmented into kits and reagents, services, filtration systems, and others. Kits and Reagents accounted for the largest market share in 2021, and is projected to grow at a CAGR of 11.72% during the forecast period. The reagents help identify viruses that may contaminate the cell substrate or other reagents or materials used in the evaluation process. Qiagen and Merck Millipore are two well-known manufacturers of reagents and kits for virus filtration. Blood, plasma, serum, bodily fluids, and any monoclonal antibody and recombinant proteins are used in the production of biopharmaceuticals.

Virus Filtration Market, By Application

• Medical Devices
• Water Purification
• Air Purification
• Biologicals
• Vaccines and Therapeutics
• Blood and Blood Products
• Cellular and Gene Therapy Products
• Others

Based on Application, the market is segmented into medical devices, water purification, air purification, and biologicals. Biologicals accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 12.08% during the forecast period. Biologicals are being used to treat and correct a wide range of medical situations and metabolic dysfunctions. Virus removal methods involve size exclusion, including filtration, adsorption to specific matrices, including chromatography, and partitioning into a different fraction. Filtration methodologies designed for viral removal applications considerably contribute to a reduction of endogenous and adventitious viral contaminants.

Virus Filtration Market, By End-User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies

Based on End-user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Pharmaceutical & Biotechnology Companies accounted for the largest market share in 2020, and is projected to grow at a CAGR of 11.64% during the forecast period. The increasing geriatric population and the rising majority of chronic medical disorders positively impact the market growth. Also, the growing need for potential therapies and vaccines to treat patients in critical conditions using viral filtration in convalescent plasma to minimize inflammatory mediators. The continued advancement of bioprocessing technologies such as disposable devices, perfusion reactors, and chromatographic resins increases the global demand for pharmaceutical & biotechnology companies.

Virus Filtration Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.
• On the basis of regional analysis, the Global Virus filtration Market is classified into North America, Europe, Asia Pacific and Rest of the world, North America accounted for the largest market share in 2021, and is projected to grow at the highest CAGR during the forecast period. The viral filtration industry in North America continued to hold a significant market share in comparison to the other regions. As the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Moreover, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the region contains several well-known firms. Europe was the second-largest market in 2021, and it is projected to grow at a CAGR.

Key Players

• The major players in the Virus Filtration Market are:
• Merck & Co.
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd.
• Pall Corporation
• Charles River Laboratories
• Sartorius AG
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VIRUS FILTRATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL VIRUS FILTRATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL VIRUS FILTRATION MARKET, BY APPLICATION

• 5.1 Medical Devices
• 5.2 Water Purification
• 5.3 Air Purification
• 5.4 Biologicals
  • 5.4.1 Vaccines and Therapeutics
  • 5.4.2 Blood and Blood Products
  • 5.4.3 Cellular and Gene Therapy Products
  • 5.4.4 Others

6 GLOBAL VIRUS FILTRATION MARKET, BY PRODUCT

• 6.1 Kits and Reagents
• 6.2 Filtration Systems
• 6.3 Services
• 6.4 Other Products

7 GLOBAL VIRUS FILTRATION MARKET, BY END USER

• 7.1 Pharmaceutical & Biotechnology Companies
• 7.2 Contract Research Organizations
• 7.3 Academic Research Institutes
• 7.4 Medical Device Companies

8 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
• 8.6 Rest of the World

9 GLOBAL VIRUS FILTRATION MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Merck & Co.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 GE Healthcare
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Thermo Fisher Scientific, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Lonza Group Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Sartorius AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Asahi Kasei Medical Co., Ltd.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Development
• 10.7 WuXi AppTec
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Development
• 10.8 Pall Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Charles River Laboratories
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research